Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies.
Saved in:
| Title: | Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies. |
|---|---|
| Authors: | Siegmund HU; Bayer Technology Services GmbH, Leverkusen, Germany., Burghaus R; Bayer Pharma AG, Wuppertal, Germany., Kubitza D; Bayer Pharma AG, Wuppertal, Germany., Coboeken K; Bayer Technology Services GmbH, Leverkusen, Germany. |
| Source: | British journal of clinical pharmacology [Br J Clin Pharmacol] 2015 Jun; Vol. 79 (6), pp. 959-66. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 25510952 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Siegmund+HU%22">Siegmund HU</searchLink>; Bayer Technology Services GmbH, Leverkusen, Germany.<br /><searchLink fieldCode="AU" term="%22Burghaus+R%22">Burghaus R</searchLink>; Bayer Pharma AG, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Kubitza+D%22">Kubitza D</searchLink>; Bayer Pharma AG, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Coboeken+K%22">Coboeken K</searchLink>; Bayer Technology Services GmbH, Leverkusen, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227503323%22">British journal of clinical pharmacology</searchLink> [Br J Clin Pharmacol] 2015 Jun; Vol. 79 (6), pp. 959-66. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7503323 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2125 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203065251%22">03065251 </searchLink><i>NLM ISO Abbreviation: </i>Br J Clin Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25510952 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bcp.12571 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 959 Titles: – TitleFull: Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Siegmund HU – PersonEntity: Name: NameFull: Burghaus R – PersonEntity: Name: NameFull: Kubitza D – PersonEntity: Name: NameFull: Coboeken K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2015 Jun Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 1365-2125 Numbering: – Type: volume Value: 79 – Type: issue Value: 6 Titles: – TitleFull: British journal of clinical pharmacology Type: main |
| ResultId | 1 |
